Last reviewed · How we verify
NCT06222528
Reducing Stigma and Increasing Treatment Seeking Intentions Among Adolescents
NA trial testing Brief video intervention (Black Girl) in Stigma, Social in 1,200 participants. Completed in 17 August 2024.
17 August 2024
Quick facts
| Lead sponsor | New York State Psychiatric Institute |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 1,200 |
| Start date | 3 June 2024 |
| Primary completion | 17 August 2024 |
| Estimated completion | 17 August 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Brief video intervention (Black Girl)
- Brief video intervention (Black Boy)
- Brief video intervention (Latinx Girl)
- Brief video intervention (Latinx Boy)
- Brief video intervention (White Girl)
- Brief video intervention (White Boy)
- Brief video intervention (Nonbinary or transgender)
- Control Condition
Conditions studied
- Stigma, Social — all drugs for Stigma, Social →
- Mental Health Disorder — all drugs for Mental Health Disorder →
- Adolescent Behavior — all drugs for Adolescent Behavior →
- Depression — all drugs for Depression →
Sponsor
New York State Psychiatric Institute
Who can join
Adults 14 to 18, any sex, with Stigma, Social or Mental Health Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Depression is a leading cause of illness and disability in teenagers. Longer duration of untreated depression (DUD) is associated with greater severity, poorer outcome, and cognitive impairment. Stigma toward people with depression has been identified as a barrier to seeking help; therefore, reducing stigma toward young people at depressive risk could enhance their receptivity to seeking treatment. Social contact is a form of interpersonal contact with members of the stigmatized group and the most effective type of intervention for improvement in stigma-related knowledge and attitudes. In a prior study, the investigators developed short video interventions to reduce stigma and increase treatment seeking among adolescents with depression. The videos feature adolescent protagonists varied by race/ethncitiy and gender (Black girl, Black boy, White girl, White boy, Hispanic girl, Hispanic boy, nonbinary or transgender adolescent) who will share their experiences with depression, challenges, and recovery process. The investigators would like to conduct a randomized controlled trial (RCT) to test the efficacy of these tailored videos as compared to a video control condition (which provides information about depression and how to seek help but does not include a personal story) on reducing self-stigma and increasing help-seeking intentions and behavior at baseline, post, 2 week follow-up, and 4 week follow-up among adolescents ages 14-18 recruited via Cloudresearch. The videos will be shown again at 2 week follow-up.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Depression stigma, treatment-seeking intentions, and barriers to care among adolescents: demographic factors in a crowdsourced sample.
Markman R, Steier K, Fisch CT, Jankowski S, et al · · 2026 · PMID 42250491 · DOI 10.1016/j.psychres.2026.117250
Verify or expand the search:
- PubMed search for NCT06222528
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stigma, Social
Currently open trials in the same condition.
- NCT07430761 — ET Stigma Response to Tremor Suppression · recruiting
- NCT04881084 — Exploring Empathy and Compassion Using Digital Narratives · NA · recruiting
- NCT05174936 — ResIlience-based Stigma REdUction Program ("Rise-up") · NA · active not recruiting
- NCT05704764 — Using the Ending Self-Stigma Intervention to Reduce Internalized Stigma Among People Living With HIV Who Use Substances · NA · active not recruiting
- NCT05404750 — Harm Reduction in HIV Primary Care for PLWH Who Use Drugs · recruiting
Other New York State Psychiatric Institute trials
Trials by the same sponsor.
- NCT05416658 — Shared Decision Making for Antipsychotic Medications · NA · not yet recruiting
- NCT07423546 — A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia · Phase 1, PHASE2 · not yet recruiting
- NCT05339256 — Sublingual Buprenorphine Through Telemedicine vs In-Person Care as Usual · Phase 2 · not yet recruiting
- NCT05563948 — Repeated Administration of Cannabis Varying in THC and CBD · Phase 2 · suspended
- NCT06977308 — A Multimodal Imaging Study of Dopamine in Early Psychosis · Phase 1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06222528 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by New York State Psychiatric Institute
- Last refreshed: 4 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06222528.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing